Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Gentamicin-loaded exosomes improve healing of infected diabetic wounds in mice.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Melatonin may help treat PCOS symptoms in rats.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Recognizing and treating early signs of insulin resistance can help prevent type 2 diabetes and improve life quality.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Diet changes can protect against harmful environmental effects on fetal development.

Low prolactin in young women may increase heart and metabolism risks.

Both contraceptive pill doses effectively reduced androgen levels in women with PCOS.

Deoxycorticosterone and its metabolites help prevent seizures by interacting with specific receptors.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Mesenchymal stem cells could help treat diabetes and its complications by improving insulin function and reducing inflammation.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

A new compound shows promise as a topical treatment for hair loss.